Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

Thaddeus R. Tolleson, L. Kristin Newby, Robert A. Harrington, Manjushri V. Bhapkar, Freek W.A. Verheugt, Peter B. Berger, David J. Moliterno, Harvey D. White, E. Magnus Ohman, Frans Van De Werf, Eric J. Topol, Robert M. Califf

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice.

Original languageEnglish
Pages (from-to)330-333
Number of pages4
JournalAmerican Journal of Cardiology
Volume92
Issue number3
DOIs
StatePublished - Aug 1 2003

Bibliographical note

Funding Information:
SYMPHONY and 2nd SYMPHONY were funded by research grants from F. Hoffmann-La Roche, Ltd., Basel, Switzerland.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)'. Together they form a unique fingerprint.

Cite this